WO2013157009A3 - Tissue treatment - Google Patents

Tissue treatment Download PDF

Info

Publication number
WO2013157009A3
WO2013157009A3 PCT/IL2013/050339 IL2013050339W WO2013157009A3 WO 2013157009 A3 WO2013157009 A3 WO 2013157009A3 IL 2013050339 W IL2013050339 W IL 2013050339W WO 2013157009 A3 WO2013157009 A3 WO 2013157009A3
Authority
WO
WIPO (PCT)
Prior art keywords
damage region
less
lumen
wall
tissue treatment
Prior art date
Application number
PCT/IL2013/050339
Other languages
French (fr)
Other versions
WO2013157009A2 (en
Inventor
Ariel Sverdlik
Iris Szwarcfiter
Or Shabtay
Original Assignee
CardioSonic Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/449,539 external-priority patent/US10967160B2/en
Priority claimed from US13/462,956 external-priority patent/US20120215106A1/en
Application filed by CardioSonic Ltd. filed Critical CardioSonic Ltd.
Publication of WO2013157009A2 publication Critical patent/WO2013157009A2/en
Publication of WO2013157009A3 publication Critical patent/WO2013157009A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N7/02—Localised ultrasound hyperthermia
    • A61N7/022—Localised ultrasound hyperthermia intracavitary
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345—Vascular system
    • A61B2018/00404—Blood vessels other than those in or around the heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00434—Neural system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00505—Urinary tract
    • A61B2018/00511—Kidney
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577—Ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0004—Applications of ultrasound therapy
    • A61N2007/0021—Neural system treatment
    • A61N2007/003—Destruction of nerve tissue

Abstract

There is provided in accordance with an exemplary embodiment of the invention a method of treating a subject suffering from a nerve related disorder, the method comprising causing a damage region to one or both of a lumen wall or nearby surrounding tissues, the damage region encompassing a volume having dimensions of less than about 6.8 mm in a substantially radial direction, less than about 5.8 mm in a direction substantially tangential to the lumen, less than about 10 mm in a substantially axial direction, the damage region being located no closer than about 0.2 mm from an inner wall of the lumen, the damage region comprises of greater than about 60% of collagen denatured tissue.
PCT/IL2013/050339 2012-04-18 2013-04-18 Tissue treatment WO2013157009A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13/449,539 2012-04-18
US13/449,539 US10967160B2 (en) 2010-10-18 2012-04-18 Tissue treatment
US13/462,956 2012-05-03
US13/462,956 US20120215106A1 (en) 2010-10-18 2012-05-03 Tissue treatment

Publications (2)

Publication Number Publication Date
WO2013157009A2 WO2013157009A2 (en) 2013-10-24
WO2013157009A3 true WO2013157009A3 (en) 2013-12-19

Family

ID=49385032

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2013/050339 WO2013157009A2 (en) 2012-04-18 2013-04-18 Tissue treatment

Country Status (1)

Country Link
WO (1) WO2013157009A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9028417B2 (en) 2010-10-18 2015-05-12 CardioSonic Ltd. Ultrasound emission element

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US20080039746A1 (en) 2006-05-25 2008-02-14 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US20120095371A1 (en) 2010-10-18 2012-04-19 CardioSonic Ltd. Ultrasound transducer and cooling thereof
US20130211396A1 (en) 2010-10-18 2013-08-15 CardioSonic Ltd. Tissue treatment
US9566456B2 (en) 2010-10-18 2017-02-14 CardioSonic Ltd. Ultrasound transceiver and cooling thereof
US10357304B2 (en) 2012-04-18 2019-07-23 CardioSonic Ltd. Tissue treatment
US11357447B2 (en) 2012-05-31 2022-06-14 Sonivie Ltd. Method and/or apparatus for measuring renal denervation effectiveness
CN107334525B (en) 2012-11-05 2019-10-08 毕达哥拉斯医疗有限公司 Controlled tissue ablation
US9770593B2 (en) 2012-11-05 2017-09-26 Pythagoras Medical Ltd. Patient selection using a transluminally-applied electric current
WO2014188430A2 (en) 2013-05-23 2014-11-27 CardioSonic Ltd. Devices and methods for renal denervation and assessment thereof
EP3139853B1 (en) 2014-05-07 2018-12-19 Pythagoras Medical Ltd. Controlled tissue ablation apparatus
US10383685B2 (en) 2015-05-07 2019-08-20 Pythagoras Medical Ltd. Techniques for use with nerve tissue
EP3457975A2 (en) 2016-05-18 2019-03-27 Pythagoras Medical Ltd. Helical catheter
CN110505900A (en) 2017-03-20 2019-11-26 索尼伟业有限公司 Method for treating heart failure by the ejection fraction for improving patient

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020026127A1 (en) * 2000-03-23 2002-02-28 Balbierz Daniel J. Tissue biopsy and treatment apparatus and method
US20110092781A1 (en) * 2009-10-12 2011-04-21 Michael Gertner Energetic modulation of nerves
WO2011060200A1 (en) * 2009-11-11 2011-05-19 Innovative Pulmonary Solutions, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US20110178441A1 (en) * 2008-07-14 2011-07-21 Tyler William James P Methods and devices for modulating cellular activity using ultrasound

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020026127A1 (en) * 2000-03-23 2002-02-28 Balbierz Daniel J. Tissue biopsy and treatment apparatus and method
US20110178441A1 (en) * 2008-07-14 2011-07-21 Tyler William James P Methods and devices for modulating cellular activity using ultrasound
US20110092781A1 (en) * 2009-10-12 2011-04-21 Michael Gertner Energetic modulation of nerves
WO2011060200A1 (en) * 2009-11-11 2011-05-19 Innovative Pulmonary Solutions, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9028417B2 (en) 2010-10-18 2015-05-12 CardioSonic Ltd. Ultrasound emission element

Also Published As

Publication number Publication date
WO2013157009A2 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
WO2013157009A3 (en) Tissue treatment
EA201491701A1 (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS
WO2010102195A3 (en) Annexin a11 and associated genes as biomarkers for cancer
WO2013056148A3 (en) Scd1 antagonists for treating cancer
WO2011133875A3 (en) Metalloenzyme inhibitor compounds
PH12018501227A1 (en) Drug for preventing and/or treating polycystic kidney disease
PH12016500270A1 (en) Combination of a mek inhibitor and an erk inhibitor for use in treatment of hyperproliferative diseases
MX2014005458A (en) Dual inhibitor of met and vegf for treating cancer.
WO2009092108A3 (en) Biomarkers for the diagnosis and treatment of pancreatic cancer
CL2017002774A1 (en) Improved uricase sequences and treatment methods
UA111148C2 (en) SIGMA LIGANDS FOR THE APPLICATION IN PREVENTION AND / OR TREATMENT OF POST-OPERATIVE PAIN
EP3302325A4 (en) Cryoablation catheter having an elliptical-shaped treatment section
GB2499559A (en) Treating cough and tussive attacks
WO2013055385A3 (en) Methods of treating age related disorders
MX2014005209A (en) A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent.
WO2014205266A3 (en) Compositions and methods for detecting and treating glioblastoma
WO2013120022A3 (en) Treatment of hypoglycemia
WO2011126842A3 (en) Targeting micrornas for the treatment of cardiac disorders
EP3133073A3 (en) Inhibitors of iap
WO2014062878A3 (en) Treatment of prostate cancer with tor kinase inhibitors
WO2014200969A3 (en) Methods of treatment of cancer
EP3490613A4 (en) Gene therapy for the treatment of aldehyde dehydrogenase deficiency
WO2012058529A3 (en) Metalloenzyme inhibitor compounds
WO2013150126A3 (en) Method for treating blood, blood products and organs
EP3702470A3 (en) Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13777564

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13777564

Country of ref document: EP

Kind code of ref document: A2